Therapy areas

US judge hacks $8-billion damages verdict against Johnson & Johnson in Risperdal case down...

US judge hacks $8-billion damages verdict against Johnson & Johnson in Risperdal case down to $6.8 million

UK, German cost-effectiveness bodies unconvinced by Bayer’s TRK inhibitor Vitrakvi

UK, German cost-effectiveness bodies unconvinced by Bayer's TRK inhibitor Vitrakvi

TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant...

TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant Forms of TB in China

Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for Stem Cell Therapy...

Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for Stem Cell Therapy Treating Neurological Disorders ...

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2020

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2020